About the Company
We do not have any company description for Tevogen Bio Holdings Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Tevogen Bio Holdings Inc.
Tevogen to Release Internal Asset Valuation; CEO Affirms Assets Are Fully Protected
Tevogen Bio Holdings Inc. (“Tevogen” or the “Company”) (Nasdaq: TVGN), today issued the following statement from Ryan Saadi, ...
Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions
Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced an update on institutional ownership of ...
Tevogen Bio Reaffirms Investor Confidence with Estimated Asset Value Exceeding $10 Billion
Tevogen Bio Holdings Inc. ('Tevogen” or the 'Company) (Nasdaq: TVGN), reiterates investor confidence and estimated asset ...
Tevogen Bio Holdings Inc. Announces Letter of Intent with CD8 ...
Tevogen Bio Holdings Inc. announced that CD8 Technology Services LLC has signed a letter of intent to design a facility that will support Tevogen’s cell therapy manufacturing efforts.
Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming ...
WARREN, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing ...
Tevogen Bio Holdings Inc. to Provide Key Updates Ahead of Annual ...
Tevogen Bio Holdings Inc. announced it will provide several updates to stockholders prior to its Annual Meeting set for June 23, 2025. The updates will cover various aspects of the company's ...
Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving ...
Contacts Tevogen Bio Communications T: 1 877 TEVOGEN, Ext 701 Communications@Tevogen.com Source: Tevogen Bio Inc 2024 GlobeNewswire, Inc.
Tevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion ...
Listing on Nasdaq is expected to provide Tevogen Bio Holdings Inc. increased access to capital to accelerate development of its genetically unmodified off-the-shelf T cell therapy products for ...
Tevogen Bio Holdings Inc. (TVGN): AI Innovations in Immunotherapy
Tevogen Bio Holdings Inc. (NASDAQ:TVGN) is a clinical-stage immunotherapy company focused on developing precision T-cell therapies using CD8+ cytotoxic T lymphocytes to treat infectious diseases ...
Why Tevogen Bio Holdings Stock Is Moving Higher Today
The line of credit grants Tevogen access to $1 million per month at an interest rate of either the daily secured overnight financing rate plus 2% or 7% accruing quarterly, depending on which is lower.
Tevogen Bio Holdings Inc. (TVGN) Secures $8M Grant, Accelerates AI ...
Tevogen Bio Holdings Inc. (NASDAQ:TVGN) is a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T-cell therapies for treating infectious diseases, cancers, and ...
Similar Companies
Loading the latest forecasts...